NutriBand (NTRB) Liabilities and Shareholders Equity (2016 - 2026)
NutriBand's (NTRB) quarterly Liabilities and Shareholders Equity came in at $7.5 million in Q1 2026, up 1.04% year-on-year from $7.5 million in Q1 2025, and down 10.35% quarter-over-quarter from $8.4 million in Q4 2025.
NutriBand (NTRB) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
NutriBand has disclosed Liabilities and Shareholders Equity across 11 years of filings, most recently posting $7.5 million for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $7.5 million, up 1.04% year-over-year; the trailing twelve-month figure through Jan 2026 was $32.3 million (down 33.82% YoY), and the FY2026 annual result was $7.5 million, up 1.04% from the prior year.
- Liabilities and Shareholders Equity came in at $7.5 million for Q1 2026 at NutriBand, down from $8.4 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $15.2 million in Q2 2024 to a low of $6.2 million in Q2 2025.
- The 5-year median for Liabilities and Shareholders Equity is $9.9 million (2023), against an average of $10.1 million.
- Across the five-year window, Liabilities and Shareholders Equity soared 74.68% in 2024 and tumbled 59.4% in 2025, its largest moves.
- NutriBand's Liabilities and Shareholders Equity stood at $10.7 million in 2022, then fell by 20.12% to $8.5 million in 2023, then surged by 47.17% to $12.5 million in 2024, then slumped by 32.88% to $8.4 million in 2025, then dropped by 10.35% to $7.5 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $7.5 million (Q1 2026), $8.4 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 640.56 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 7.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 7.55 Mn |
| Oct 31, 2025 | 8.42 Mn |
| Jul 31, 2025 | 10.18 Mn |
| Apr 30, 2025 | 6.15 Mn |
| Jan 31, 2025 | 7.47 Mn |
| Oct 31, 2024 | 12.54 Mn |
| Jul 31, 2024 | 13.63 Mn |
| Apr 30, 2024 | 15.15 Mn |
| Jan 31, 2024 | 7.52 Mn |
| Oct 31, 2023 | 8.52 Mn |
| Jul 31, 2023 | 9.87 Mn |
| Apr 30, 2023 | 8.68 Mn |
| Jan 31, 2023 | 9.46 Mn |
| Oct 31, 2022 | 10.67 Mn |
| Jul 31, 2022 | 11.39 Mn |
| Apr 30, 2022 | 11.98 Mn |
| Jan 31, 2022 | 12.74 Mn |
| Oct 31, 2021 | 15.43 Mn |
| Jul 31, 2021 | 10.16 Mn |
| Apr 30, 2021 | 10.56 Mn |